Skip to content

RNTX RNTX Other Non-Current Assets

Other Non-Current Assets at other companies

CTO
Citius Oncology, Inc.CTOR
$71.28M-2.9%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$148K+124%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$4.94M-11.1%
LQD
Liquidia CorporationLQDA
$16.9M+8.7%
United Therapeutics logo
United TherapeuticsUTHR
$233.2M+4.9%
Insmed logo
InsmedINSM
$99.28M+10.6%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's other non-current assets?
RNTX (RNTX) reported other non-current assets of $1.01M in Q1 2026.
How has RNTX's other non-current assets changed year-over-year?
RNTX's other non-current assets increased by 31.2% year-over-year, from $766K to $1.01M.
What is the long-term trend for RNTX's other non-current assets?
Over 4 years (2021 to 2025), RNTX's other non-current assets has grown at a -46.3% compound annual growth rate (CAGR), from $24K to $2K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.